12-21806064-CAAA-CAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_020297.4(ABCC9):​c.4450-5delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 997,342 control chromosomes in the GnomAD database, including 165 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 131 hom., cov: 32)
Exomes 𝑓: 0.11 ( 34 hom. )

Consequence

ABCC9
NM_020297.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 0.729

Publications

3 publications found
Variant links:
Genes affected
ABCC9 (HGNC:60): (ATP binding cassette subfamily C member 9) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel-modulating subunit of the extra-pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated with cardiomyopathy dilated type 1O. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2011]
ABCC9 Gene-Disease associations (from GenCC):
  • hypertrichotic osteochondrodysplasia Cantu type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dilated cardiomyopathy 1O
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intellectual disability and myopathy syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • acromegaloid facial appearance syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrichosis-acromegaloid facial appearance syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • atrial fibrillation, familial, 12
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 12-21806064-CA-C is Benign according to our data. Variant chr12-21806064-CA-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 35634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0857 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC9NM_020297.4 linkc.4450-5delT splice_region_variant, intron_variant Intron 38 of 39 ENST00000261200.9 NP_064693.2 O60706-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC9ENST00000261200.9 linkc.4450-5delT splice_region_variant, intron_variant Intron 38 of 39 5 NM_020297.4 ENSP00000261200.4 O60706-2

Frequencies

GnomAD3 genomes
AF:
0.0278
AC:
3894
AN:
140288
Hom.:
131
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0880
Gnomad AMI
AF:
0.00113
Gnomad AMR
AF:
0.0139
Gnomad ASJ
AF:
0.000602
Gnomad EAS
AF:
0.000611
Gnomad SAS
AF:
0.000667
Gnomad FIN
AF:
0.00781
Gnomad MID
AF:
0.0101
Gnomad NFE
AF:
0.00288
Gnomad OTH
AF:
0.0231
GnomAD2 exomes
AF:
0.297
AC:
22913
AN:
77272
AF XY:
0.304
show subpopulations
Gnomad AFR exome
AF:
0.343
Gnomad AMR exome
AF:
0.307
Gnomad ASJ exome
AF:
0.307
Gnomad EAS exome
AF:
0.295
Gnomad FIN exome
AF:
0.225
Gnomad NFE exome
AF:
0.295
Gnomad OTH exome
AF:
0.289
GnomAD4 exome
AF:
0.114
AC:
97432
AN:
856984
Hom.:
34
Cov.:
0
AF XY:
0.114
AC XY:
47782
AN XY:
420852
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.207
AC:
4521
AN:
21818
American (AMR)
AF:
0.155
AC:
3717
AN:
23946
Ashkenazi Jewish (ASJ)
AF:
0.121
AC:
1719
AN:
14172
East Asian (EAS)
AF:
0.104
AC:
2268
AN:
21858
South Asian (SAS)
AF:
0.138
AC:
6269
AN:
45314
European-Finnish (FIN)
AF:
0.116
AC:
3434
AN:
29642
Middle Eastern (MID)
AF:
0.0744
AC:
277
AN:
3722
European-Non Finnish (NFE)
AF:
0.107
AC:
70958
AN:
661016
Other (OTH)
AF:
0.120
AC:
4269
AN:
35496
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.257
Heterozygous variant carriers
0
13783
27565
41348
55130
68913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2696
5392
8088
10784
13480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0279
AC:
3910
AN:
140358
Hom.:
131
Cov.:
32
AF XY:
0.0278
AC XY:
1890
AN XY:
67882
show subpopulations
African (AFR)
AF:
0.0882
AC:
3411
AN:
38692
American (AMR)
AF:
0.0139
AC:
193
AN:
13924
Ashkenazi Jewish (ASJ)
AF:
0.000602
AC:
2
AN:
3322
East Asian (EAS)
AF:
0.000817
AC:
4
AN:
4894
South Asian (SAS)
AF:
0.00111
AC:
5
AN:
4488
European-Finnish (FIN)
AF:
0.00781
AC:
63
AN:
8070
Middle Eastern (MID)
AF:
0.0109
AC:
3
AN:
274
European-Non Finnish (NFE)
AF:
0.00288
AC:
184
AN:
63888
Other (OTH)
AF:
0.0229
AC:
44
AN:
1924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
162
324
486
648
810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0920
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dilated cardiomyopathy 1O Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 02, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiomyopathy Benign:1
Mar 26, 2019
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Primary dilated cardiomyopathy Benign:1
May 08, 2019
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 29, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hypertrophic cardiomyopathy 2 Other:1
-
Institute of Human Genetics, University of Wuerzburg
Significance:not provided
Review Status:no classification provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.73
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4148680; hg19: chr12-21958998; COSMIC: COSV53972138; API